ToxicologyEmergencyCardiology
Digoxin toxicity
Recognition of digoxin toxicity including arrhythmia patterns, hyperkalaemia and digoxin-specific antibody (DigiFab) indications.
Source: TOXBASE/NPIS; ESC; BNF; SmPC DigiFab
Step 1 of ~6
action
Identify acute vs chronic and assess severity
Acute: large single ingestion in non-toxic patient — early hyperkalaemia, hypotension, bradyarrhythmia. Chronic: established therapy + precipitant (renal impairment, hypokalaemia, hypomagnesaemia, hypercalcaemia, age, drug interactions: amiodarone, verapamil, diltiazem, macrolides, ciclosporin).
Features: nausea, vomiting, abdominal pain, anorexia, confusion, visual changes (xanthopsia, halos), bradyarrhythmias, AV block, atrial tachycardia with block (hallmark), bidirectional VT.
ABCDE; continuous ECG; bloods: digoxin level (>6 h post-dose for steady state), U&E (K⁺ critical), magnesium, calcium, creatinine, paracetamol/salicylate. ECG (look for AT with block, scooped ST, regularised AF, ventricular ectopy).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Same class
Pathways
- Paracetamol overdose · TOXBASE/NPIS; MHRA DSU 2012/2024; SNAP regimen (Lancet 2014); BNF
- TCA overdose · TOXBASE/NPIS; AACT/EAPCCT position statements; Resuscitation Council UK ALS
- Opioid overdose · TOXBASE/NPIS; Resuscitation Council UK; BNF
- Anticholinergic toxidrome · TOXBASE/NPIS; AACT/EAPCCT; BNF
- Benzodiazepine overdose · TOXBASE/NPIS; AACT/EAPCCT; BNF
- β-blocker overdose · TOXBASE/NPIS; AACT/EAPCCT; ESC; BNF
Decision support only. Always apply local guidelines and clinical judgement.